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The methanolic extract (GSM) prepared from the stem bark of Garcinia smeathmannii as well as ten compounds isolated from this crude
extract, were tested for their antimicrobial activity against Gram-positive bacteria (6 species), Gram-negative bacteria (12 species) and 3 Candida
species using well micro-dilution methods. The GSM showed very interesting inhibition effects on the growth of the tested pathogens with the
minimal inhibition concentrations (MIC) lower than 156.25 μg/mL on 21 of the 22 pathogens tested. Purified compounds showed selective
activities. Two of these compounds namely Cheffouxanthone (1) and Friedelin (9) exhibited both antibacterial and anticandidal activities. The
antimicrobial activity of compounds 1, Bangangxanthone A (4), and Guttiferone I (7), as well as that of GSM is being reported for the first time.
The overall results provide promising baseline information for the potential use of the crude extract from the stem bark of G. smeathmannii as
well as some of the isolated compounds in the treatment of bacterial and fungal infections.
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Infectious diseases constitute one of the main problems that
modernmedicine had to face these last 30 years. Despite the high
proportion of efficient antibiotics available nowadays, the emer-
gence of resistant microorganisms has lowered their potency
(Bacq-Calberg et al., 1999). These problems, along with the high
incidence of poverty within population orientated the African
population more and more towards the folk medicine. Today,
about 80% of Africans ask for help to tradi-therapists or herba-
lists in the treatment of various diseases. In Cameroon, many
medicinal plants from Clusiaceae family are used as herbal
medicines. Within this family, plants of Garcinia genus, which
grow in the lowland tropical rain forest of West Africa and Asia
have been reported to possess antimicrobial properties (Watt and
Breyer-Brandwijk, 1962; Hiroyuki et al., 1996). Xanthones and
flavonoids were found to be the major compounds associated to
the therapeutic potential of Garcinia species (Hiroyuki et al.,⁎ Corresponding author. Tel.: +237 735 59 27/+237 533 84 55; fax: +237 222
60 18.
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0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.01.0041996; Waterman and Hussain, 1982; Iwu et al., 1990). Among
the different species of Garcinia genus, Garcinia smeathmannii
Oliver is extensively used by the local population of Cameroon
for the treatment of bacterial and fungal infections. The anti-
microbial activity of some of the compounds from the stem bark
of this plant such as Smeathxanthones A and B, was reported in
our previous paper (Komguem et al., 2005). Nevertheless, the
inhibitory activity of the crude extract of this plant is not yet
documented to the best of our knowledge. This study therefore
reports the antimicrobial activity of this extract, with that of a
number of compounds isolated from this extract.
2. Materials and methods
2.1. General experimental procedures
Melting points were recorded on a Cipla I-28 digital appa-
ratus and were uncorrected. Aluminium sheet pre-coated
with silica gel 60 F254 nm (Mereck) was used for thin layer
chromatography and the isolated spots were visualized using
both ultra-violet light (254 and 366 nm) and 10% H2SO4
spray reagent. The chemical structure of each of the isolatedts reserved.
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produced by one and two-dimensional nuclear magnetic re-
sonances (NMR), recorded on Brüker DRX-400 instrument.
This spectrometer was equipped with 5-mm, 1H- and 13C-NMR
probes operating at 400 and 100MHz, with tretramethylsilane as
internal standard. Mass spectra were recorded on a API QSTAR
pulsar mass spectrometer. The structures of the compounds
(Figs. 1 and 2) were confirmed by their spectroscopic data in
accordance with that of reference from available literature.
2.2. Plant material
The stem bark of G. smeathmannii was collected in Baham,
in the West province of Cameroon. A botanist, Mr. Victor Nana
in the national herbarium of Cameroon, identified the plant. The
voucher specimen was deposited under the reference number
35169/HNC.
2.3. Extraction
The plant material was finely cut into pieces, dried and ground
to yield a powder. Then, 5 kg of this powder were macerated in
methanol (20 L) for 72 h. The filtrate obtained using Whatman
filter paper no. 1 was concentrated under vacuum to give crude
extract (180 g; 3.6%). This was stored at 4 °C till further use.
2.4. Isolation and identification of compounds
One hundred grams (100 g) of crude extract were exhausted
with hexane to give 18 g of hexanic fraction (A) and 73 g of
remaining extract (B). Fraction (A) was subjected to silica gel
60 (0.063–0.200 mm) column chromatography, using hexane–
EtOAc gradient (99:1 to 85:15) as eluent at 2 mL min. Sub-
fractions of 100 mL each were collected, concentrated under
vacuum and pooled according to TLC analysis. This separation
yielded Friedelin C30H50O (9) (White crystals; 30 mg in
hexane–EtOAc acetate 95:5; m.p.: 265–266; m/z 426) (Guna-
tilaka et al., 1982), Smeathxanthone B C23H22O6 (5) (yellowFig. 1. Chemical structures of xanthones isolated fcrystals; 120 mg in hexane–EtOAc 90:10; Rf: 0.27 using
hexane–EtOAc 95:5; m.p.: 187–189; m/z 394) (Komguem
et al., 2005) and one major sub-fraction (A1; 4 g obtained in
hexane–Ethyl acetate 90:10 to 85:15). A1 was chromato-
graphed over silica gel 60 using CH2Cl2–MeOH (98:2) elution
system at 1 mLmin. Sub-fractions of 15 mL each were collected
and the separation yielded Triacontanyl cafeate C39H68O4 (10)
(75 to 285 mL; white crystals; 17 mg; m.p.: 103–104, m/z 600)
(Hesham et al., 2003), and Guttiferone I C43H58O6 (7) (yellow
oil; 330 to 525 mL; 25 mg; m/z 670; Rf: 0.38 using CH2Cl2–
MeOH 95:5) (Herath et al., 2005).
Fifty grams (50 g) of fraction B were subjected to flash
chromatography over silica gel 60 using hexane–EtOAc gra-
dient (95:5 to 75:25) at 2 mL min. The sub-fractions of 150 mL
each were collected, concentrated under vacuum and pooled on
the basis of analytic TLC. This afforded 2 major sub-fractions
namely B1 (hexane–EtOAc 90:10; 6.15 L, 12 g) and B2
(hexane–EtOAc 85:15 to 80:20; 5.25 L, 16 g). Further silica gel
60 column chromatography of B1 using hexane–EtOAc gra-
dient (90:10 to 80:20) at 1 mL min yielded Cheffouxanthone
C23H24O6 (1) (yellow crystals; 25 mg in hexane–EtOAc 90:10;
m.p.: 155–158; m/z 396; Rf: 0.33 using hexane–EtOAc 95:5;)
(Meli et al., 2006), Smeathxanthone A C23H24O6 (6) (yellow
crystals; 65 mg in hexane–EtOAc 88:12; m.p.: 216–218; m/z
396; Rf: 0.67 using hexane–EtOAc 95:5) (Komguem et al.,
2005), and 1,5 dihydroxyxanthone C13H8O4 (2) (yellow crys-
tals; 35 mg in hexane–EtOAc 85:15; m.p.: 264–266; m/z: 228)
(Gunasekera, 1975).
The purification of B2 over silica gel 60 using hexane–
EtOAc gradient (85:15 to 75:25) at 1 mL min yielded 1,3,5-
trihydroxyxanthone C13H8O5 (3) (yellow crystals; 20 mg in
hexane–EtOAc 85:15; m.p.: 302–305; m/z 244) (Locksley and
Murray, 1971), Isoxanthochymol C38H50O6 (8) [yellow crys-
tals; 23 mg in hexane–EtOAc 80:20; [α]D + 186 (c 0.06,
CH3COCH3); m.p.: 246–248; m/z 602] (Iinuma et al., 1996)
and another 7 g of sub-fraction (B1.1) essentially obtained with
the system hexane–EtOAc 90:10. B1.1 was finally column
chromatographed over silica gel 60 using petroleum ether–rom the stem bark of Garcinia smeathmannii.
Fig. 2. Chemical structures of the Benzophenones, triterpene and cinamate isolated from the stem bark of Garcinia smeathmannii.
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20 mL each were collected. This purification yielded Bangang-
xanthone A C23H22O6 (4) (yellow crystals; 140 to 660 mL;
45 mg; m.p.: 199–201; m/z 394; Rf: 0.38 using hexane–EtOAc
95:5) (Meli et al., 2005).
2.5. Preliminary phytochemical analysis of the crude extract
The major groups of secondary metabolites of GSM were
screened using the common methods described by Harbone
(1973).
2.6. Preparation of the standard inoculum
The cell suspension of about 1.5 ċ 106 CFU/mL obtained
from a McFarland turbidity standard no. 0.5 was used in the
antimicrobial testing. The suspension was standardised by ad-
justing the optical density to 0.1 at 600 nm (SHIMADZU UV-
120–01 spectrophotometer) (Tereschuk et al., 1997).
2.7. Antimicrobial assays
The MICs of the tested samples and the reference antibiotics
were determined as follows: the tested sample was first of alldissolved in DMSO and the solution obtained was added to the
phenol red (0.01%) containing-nutrient broth, and supplemen-
ted with 10% glucose (NBGP) to make a final concentration of
156.25 μg/mL for crude extract and 19.53 μg/mL for the iso-
lated compounds or the reference antibiotics. This was serially
diluted two fold to obtain concentration ranges of 0.61 to
156.25 μg/mL and 0.038 to 19.53 μg/mL for crude extract and
purified compounds respectively. One hundred microliter
(100 μL) of each concentration was added in a well (96-well
microplate) containing 95 μL of NBGP and 5 μL of standard
inoculum. The final concentration of DMSO in the well was less
than 1% (preliminary analyses with 1% (v/v) DMSO/NBGP
affected neither the growth of the test organisms nor the change
of colour due to this growth). The negative control wells,
consisted of 195 μL of NBGP and 5 μL of the standard ino-
culum (Zgoda and Porter, 2001). The plates were covered with a
sterile plate sealer, then agitated to mix the content of the wells
using a plate shaker, then incubated at 37 °C for 24 h. Each
assay was repeated twice. The microbial growth was determined
by observing the change of colour in the wells (red when there is
no growth and yellow when there is growth). The lowest con-
centration showing no colour change was considered as the MIC.
For the determination of MMC, a portion of liquid (5 μL)
from each well that showed no change in colour was plated on
350 V. Kuete et al. / South African Journal of Botany 73 (2007) 347–354the Mueller Hinton Agar and incubated at 37 °C for 24 h. The
lowest concentration that yielded no growth (no colony of
microorganism on the Mueller Hinton Agar medium) after this
sub-culturing was taken as the MMC (Carbonnelle et al., 1987).
3. Results and discussion
The preliminary phytochemical analysis of GSM indicated
the presence of the group compounds such as alkaloids, phe-
nols, polyphenols, saponins, tannins, triterpenes, anthraqui-
nones, flavonoids and steroids. Many compounds belonging to
these secondary metabolite groups have been reported to their
antimicrobial activities (Cowan, 1999).
The chemical structures of the isolated compounds (Figs. 1
and 2) were elucidated by their 1H-NMR spectroscopic. They
were identified as xanthones [Cheffouxanthone (1); 1,5 dihy-
droxyxanthone (2); 1,3,5-trihydroxyxanthone (3); Bangang-
xanthone A (4); Smeathxanthone B (5); Smeathxanthone A (6)],
benzophenone [Guttiferone I (7); Isoxanthochymol (8)], triter-
pene [Friedelin (9)] and cinamate [Triacontanyl cafeate (10)].
This result is in accordance with the preliminary phytochemical
analysis, since all of the isolated compounds belong to the
investigated group of secondary metabolites. Our research
group has previously reported the isolation of compounds 2, 4
and 9 from Garcinia polyanta (Meli et al., 2005), compounds 1
(Meli et al., 2006), 3, 5, and 6 from G. smeathmannii (Kom-
guem et al., 2005). Also, compound 7 has been isolated recently
from Garcinia humulis (Herath et al., 2005).
The methanolic extract showed a very interesting inhibition
effects on the growth of the tested microorganisms with MIC b
156.25 μg/mL on 21 of the 22 tested microbial species (Table 1).
Only Salmonella typhimurium was found to be resistant to this
extract. However, the growth inhibition of S. typhimurium could
also be expected at MIC N 156.25 μg/mL, as compounds 9 and
10were found to possess inhibitory effects on the pathogen. The
presence of the antimicrobial components from the investigated
metabolite groups could eventually explain the inhibitory po-
tency of the methanolic extract of this plant. The observed
activity could also explain the traditional use of this plant in the
treatment of infectious diseases.
Purified compounds showed selective activities. Two of the
ten isolated compounds (1 and 9) exhibited both antibacterial
and anticandidal activities at 19.53μg/mL limitMIC value tested
(Table 1). Considering the limit MIC value retained in this work
(19.53μg/mL), compounds 1 and 9 presented themost important
antimicrobial spectra; their inhibitory activities have been
observed respectively on 13 and 12 of the 22 tested mic-
roorganisms. The MIC values varied from 0.6 μg/mL (1.02 μM)
to 4.88 μg/mL (8.10 μM) for compound 9 while the correspond-
ing interval ranged from 4.88 μg/mL (12.33 μM) to 19.53 μg/mL
(49.3 μM) for compound 1 (Table 1). Other compounds showed
microbial growth inhibition on nine (4), eight (3 and 10), seven
(2), five (7) and two (5, 6 and 8) of the 22 tested microorganisms.
Though, the tested compounds presented spectra lower than that
of the reference antibiotics, the degree of sensitivity of the
inhibited microorganisms can be considered as very interesting.
However, theMIC values obtained with compounds 3, 4, 7 and 9were lower than that of the reference antibiotics on all inhibited
bacteria and yeasts. Furthermore, other compounds have
presented the MIC values lower than that of the reference
antibiotics on at least one of the tested microorganisms. The
lowest MIC value of 0.076 μg/mL or 0.16 μM for compound 4
on Pseudomonas aeruginosa is 5.62 times lower than that
of Gentamycin (0.9 μM). Apart from the MIC values of 1 on
Bacillus stearothermophilus and Candida gabrata, that of 10 on
S. typhimurium, all tested compounds gave values lower than
19.53 μg/mL on the sensitive microorganisms. The results from
the Minimal Microbicidal Concentration (MMC) determination
(Table 2) showed that the values lower than 156.25 μ/mL were
obtained with GSM on 14 of the 21 sensitive microbial species.
A keen look of the results of Tables 1 and 2, theMIC values are 4
times lower than the MMCs on corresponding (sensitive) mic-
roorganisms showing that the microbicidal effects could be
expected (Carbonnelle et al., 1987).
Numerous studies have documented the antimicrobial
potency of the crude extracts from genus Garcinia as well as
that of some of their antimicrobial components. Mackeen et al.
(2000) reported the antibacterial and antifungal activities of
crude methanolic extract from different parts of Garcinia
atroviridis. Significant antifungal activity of G. atroviridis
against Cladosporium herbarum was most notably noted with
the fruit, and the leaf extracts (Mackeen et al., 2000). The
antimicrobial principles of this genus were generally found to be
xanthones such as cowaxanthones from Garcinia cowa
(Panthong et al., 2006), parvifolixanthones from Garcinia
parvifolia (Rukachaisirikul et al., 2006), dulcisxanthones from
Garcinia dulcis (Deachathai et al., 2006), tetraprenylated
xanthones, named scortechinones from Garcinia scortechinii
(Rukachaisirikul et al., 2000), and phloroglucinols from
G. parvifolia (Rukachaisirikul et al., 2006). Also α-mangostin,
isolated from the stem bark of Garcinia mangostana L., was
found to be active against vancomycin resistant enterococci and
methicillin resistant Staphylococcus aureus (Sakagami et al.,
2005). The inhibitory potency of xanthones isolated from
G. smeathmannii, corroborate therefore with their findings.
Though the antimicrobial activity of triterpenes from Garcinia
species is not well documented, Friedelin is a well-known
antibiotic (Kuete et al., 2007).
The results presented in the present paper can be considered as
very promising in the perspective of new drugs discovery from
plant sources. The antimicrobial activity of crude extract from
G. smeathmannii as well as that of Cheffouxanthone (1),
Bangangxanthone A (4) and Guttiferone I (7) is being reported
for the first time. However, the antimicrobial potencies of
compounds 5 and 6 on very limited number of strains were
documented in our previous paper (Komguem et al., 2005).
Though presenting very weak antimicrobial spectra in the
present study, it has been shown that compounds 5 and 6 are
potential antimicrobials at higher doses (Komguem et al., 2005).
Kilham (2004) has also demonstrated good antibacterial
activity (mostly against S. aureus), a good antifungal activity
against Pseudallescheria boydii, and a moderate activity against
Trichophytonschoenleiniiofcompound9.Theinhibitionpotencyof
many benzophenones, including compound 8 has also been
Table 1
Minimal inhibition concentration (MIC) of compounds from the stem bark of Garcinia smeathmannii and reference antibiotics
Microbial strains a MIC in μg/mL and in μM (in parenthesis) of tested samples b
GSM 1 2 3 4 5 6 7 8 9 10 RAc
Gram-negative bacteria
C. freundii 156.25 9.76 (24.65) – 1.22 (6.35) 0.61 (1.26) – – 1.22 (1.96) – – 9.76 (22.93) 4.88 (0.9)
E. aerogens 78.12 – – – – – – – – – – 9.76 (1.8)
E. cloaclae 156.25 9.76 (24.65) – – 0.61 (1.26) – – 1.22 (1.96) – 0.61 (1.02) – 4.88 (0.9)
E. coli 39.06 – – – 0.61 (1.26) – – – – – 1.22 (0.23)
K. pneumonia 78.12 – – 0.31 (1.59) – – – – – – – 2.44 (0.45)
M. morganii 78.12 9.76 (24.65) 9.76 (55.45) – 0.15 (0.31) – – – – – 9.76 (22.93) 2.44 (0.45)
P. mirabilis 156.25 – – – – – – – – – – 2.44 (0.45)
P. vulgaris 78.12 – – 1.22 (6.35) – – – 1.22 (1.96) – 1.22 (2.03) – 1.22 (0.23)
P. aeruginosa 78.12 – – – 0.076(0.16) – – – – – 0.61 (1.43) 4.88 (0.9)
S. dysenteria 156.25 9.76 (24.65) 9.76 (55.45) 0.61 (3.18) 0.61 (1.26) – – – – 1.22 (2.03) – 2.44 (0.45)
S. flexneri 78.12 9.76 (24.65) 9.76 (55.45) 0.61 (3.18) 1.22 (2.51) – – – – 1.22 (2.03) – 2.44 (0.45)
S. typhi 78.12 – – – – – – – – 0.61 (1.02) 9.76 (22.93) 2.44 (0.45)
S. typhimurium – – – – – – 1.22 (2.03) 19.53 (45.85) 1.22 (0.23)
Gram-positive bacteria
B. cereus 156.25 9.76 (24.65) 4.88 (27.73) 1.22 (6.35) 4.88 (12.29) 9.76 (24.77) – 9.76 (16.21) – 4.88 (11.46) 1.22 (0.23)
B. megaterium 78.12 9.76 (24.65) 1.22 (6.93) 1.22 (6.35) – – – 0.61 (0.98) – 1.22 (2.03) 2.44 (5.73) 2.44 (0.45)
B. stearothermophilus 156.25 19.53 (49.3) – – 0.61 (1.26) – – – 4.88 (8.10) 1.22 (2.03) – 4.88 (0.9)
B. subtilis 39.06 – 2.44 (13.86) – – 9.76 (24.58) 9.76 (24.77) – – – – 1.22 (0.23)
S. faecalis 78.12 9.76 (24.65) 0.61 (3.46) 0.61 (3.18) 0.61 (1.26) – – 0.61 (0.98) – 0.61 (1.02) 2.44 (5.73) 2.44 (0.45)
S. aureus 156.25 9.76 (24.65) – – – – – – – – – 1.22 (0.23)
Yeasts
C. albicans 156.25 9.76 (24.65) – – – – – – – 2.44 (4.05) – 9.76 (1.04)
C. krusei 156.25 4.88 (12.33) – – – – – – – 4.88 (8.10) – 4.88 (0.52)
C. gabrata 156.25 19.53 (49.3) – – – – – – – 2.44 (4.05) – 9.76 (1.04)
a Microbial strains: C. freundii: Citrobacter freundii; E. aerogens: Enterobacter aerogens; E. cloaclae: Enterobacter cloaclae; E. coli: Escherichia coli; K. pneumonia: Klebsiella pneumonia; M. morganii:
Morganella morganii; P. mirabilis: Proteus mirabilis; P. vulgaris: Proteus vulgaris; P. aeruginosa: Pseudomonas aeruginosa; S. dysenteria: Shigella dysenteria; S. flexneri: Shigella flexneri; S. typhi: Salmonella
typhi; S. typhimurium: Salmonella typhimurium; B. cereus: Bacillus cereus; B. stearothermophilus: Bacillus stearothermophilus; B. subtilis: Bacillus subtilis; S. faecalis: Streptococcus faecalis; S. aureus: Staphylococcus
aureus;C.albicans:Candidaalbicans;C.krusei:Candidakrusei;Candidagabrata:Candidagabrata.
b Tested samples [GSM: methanolic extract, Cheffouxanthone (1); 1,5 dihydroxyxanthone (2); 1,3,5-trihydroxyxanthone (3); Bangangxanthone A (4); Smeathxanthone B (5); Smeathxanthone A (6), Guttiferone I
(7); Isoxanthochymol (8), Friedelin (9) and cinamate Triacontanyl cafeate (10)].
c RA: reference antibiotics (Gentamycin for bacteria, Nystatin for yeast); (–): MIC N156.25 and 19.53 μg/mL respectively for GSM and pure compounds.
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Table 2
Minimal microbicidal concentration (MMC) of compounds from the stem bark of Garcinia smeathmannii and reference antibiotics
Microbial strains a MMC in μg/mL and in μM (in parenthesis) of tested samples b
GSM 1 2 3 4 5 6 7 8 9 10 RAc
Gram-negative bacteria
C. freundii N156.25 19.53 (49.3) – 9.76 (25.4) 1.22 (2.51) – – 2.44 (3.92) – – 19.53 (45.85) 9.76 (1.8)
E. aerogens 156.25 – – – – – – – – – – 19.53 (3.6)
E. cloaclae N156.25 9.76 (24.65) – – 1.22 (2.51) – – 2.44 (3.92) – 1.22 (2.03) – 9.76 (1.8)
E. coli 78.12 – – – 1.22 (2.51) – – – – – 2.44 (0.45)
K. pneumonia N156.25 – – 0.61 (3.18) – – – – – – – 4.88 (0.90)
M. morganii 156.25 19.53 (49.3) 19.53 (90.9) – 0.61 (1.26) – – – – – 19.53 (45.85) 4.88 (0.90)
P. mirabilis N156.25 – – – – – – – – – – 4.88 (0.90)
P. vulgaris 156.25 – – 1.22 (6.35) – – – 2.44 (3.92) – 4.88 (8.12) – 2.44 (0.45)
P. aeruginosa 156.25 – – – 0.15 (0.31) – – – – – 1.22 (2.86) 9.76 (1.8)
S. dysenteria 156.25 9.76 (24.65) 19.53 (90.9) 1.22 (6.35) 1.22 (2.51) – – – – 2.44 (4.06) – 4.88 (0.90)
S. flexneri 78.12 9.76 (24.65) 9.76 (55.45) 1.22 (6.35) 2.44 (5.02) – – – – 2.44 (4.06) – 4.88 (0.90)
S. aureus N156.25 19.53 (49.3) – – – – – – – – – 2.44 (0.45)
S. typhi >156.25 – – – – – – – – 1.22 (2.03) 19.53 (45.85) 4.88 (0.90)
S. typhimurium – – – – – – – – – 4.88 (8.12) N19.53 (45.85) 2.44 (0.45)
Gram-positive bacteria
B. cereus 156.25 9.76 (24.65) 9.76 (55.45) 2.44 (12.7) 9.76 (24.58) 19.53 (49.54) – 19.53 (32.42) – 9.76 (22.93) 2.44 (0.45)
B. megaterium 156.25 19.53 (49.3) 4.88 (27.73) 2.44 (12.7) – – – 1.22 (1.96) – 2.44 (4.06) 4.88 (11.43) 4.88 (0.90)
B. stearothermophilus 156.25 N19.53 (49.3) – – 1.22 (2.51) – – – 9.76 (16.21) 4.88 (8.12) – 9.76 (1.8)
B. subtilis 78.12 – 4.88 (27.73) – – 19.53 (49.16) 19.53 (49.54) – – – – 2.44 (0.45)
S. faecalis 78.12 9.76 (24.65) 1.22 (6.93) 1.22 (6.35) 1.22(2.51) – – 1.22 (1.96) – 2.44 (4.06) 9.76 (22.93) 4.88 (0.90)
Yeasts
C. albicans N156.25 19.53 (49.3) – – – – – – – – – 19.53 (2.08)
C. krusei N156.25 9.76 (24.65) – – – – – – – – – 9.76 (1.04)
C. gabrata 156.25 N19.53 (49.3) – – – – – – – – – 19.53 (2.08)
a Microbial strains: C. freundii: Citrobacter freundii; E. aerogens: Enterobacter aerogens; E. cloaclae: Enterobacter cloaclae; E. coli: Escherichia coli; K. pneumonia: Klebsiella pneumonia; M. morganii:
Morganella morganii; P. mirabilis: Proteus mirabilis; P. vulgaris: Proteus vulgaris; P. aeruginosa: Pseudomonas aeruginosa; S. dysenteria: Shigella dysenteria; S. flexneri: Shigella flexneri; S.typhi: Salmonella
typhi; S. typhimurium: Salmonella typhimurium; B. cereus: Bacillus cereus; B. stearothermophilus: Bacillus stearothermophilus; B. subtilis: Bacillus subtilis; S. faecalis: Streptococcus faecalis; S. aureus: Staphylococcus
aureus;C.albicans:Candidaalbicans;C.krusei:Candidakrusei;Candidagabrata:Candidagabrata.
b Tested samples [GSM: methanolic extract, Cheffouxanthone (1); 1,5 dihydroxyxanthone (2); 1,3,5-trihydroxyxanthone (3); Bangangxanthone A (4); Smeathxanthone B (5); Smeathxanthone A (6), Guttiferone I
(7); Isoxanthochymol (8), Friedelin (9) and cinamate Triacontanyl cafeate (10)].
c RA: reference antibiotics (Gentamycin for bacteria, Nystatin for yeast); (–): not tested because MIC was not determined.
352
V.
K
uete
et
al.
/
South
A
frican
Journal
of
B
otany
73
(2007)
347–354
353V. Kuete et al. / South African Journal of Botany 73 (2007) 347–354demonstratedagainstmethycillin-resistantS.aureus (Iinumaet al.,
1996). The tested compounds are potentially responsible for the
antimicrobial activityofGSM.The results obtainedwithGSMand
compound4onPseudomonasaeruginosa isveryinterestingdue to
the fact that this microorganism has emerged as one of the most
problematic Gram-negative pathogens, with alarmingly high
antibiotics resistance rates (Bacq-Calberg et al., 1999; Gangoué,
2000; Savafi et al., 2005). Evenwith the most effective antibiotics
against this pathogen, namely carbapenems (imipenem and
meropenem), the resistance rates were detected as 15% to 20.4%
among 152 P. aeruginosa strains (Savafi et al., 2005). Also, the
results obtained for all themicroorganisms testedwere interesting,
duetothefact that theywereallselectedasmultiresistantstrainsand
thattheyaremedicallyveryimportant.BacillusspeciesespeciallyB.
cereusisanagentoffoodpoisoning(Avril,1997;SleighandTimbury,
1998;).S. typhimurium is etiologically themost important agent of
food toxi-infections (Avril, 2000). Candida albicans and other
Candida species, causing candidiasis, are increasingly important
diseasesworldwidedistributed,duetothefact that theyarefrequent
opportunistic pathogen in AIDS patients (Cowan, 1999). The
incidence of the typhoid fever caused by Salmonella typhi is
increasing indevelopingcountrynowadays.
The antimicrobial mechanisms associated to each group of
chemical to which the isolated compounds belong, may explain
the inhibition potency of the tested samples.
Membrane disruption could be suggested as one of the likely
mechanisms of action of compound 9, a triterpene (Cowan, 1999;
Arvind et al., 2004). Also, xanthones are known to complex
irreversiblywithnucleophilicaminoacidsinproteins,oftenleading
totheinactivationofproteinsandlossoffunction(Sternetal.,1996).
Thiscouldalsoexplaintheantimicrobialactivityofcompounds1to6,
theantimicrobialxanthonesisolatedfromthisplant.
The results of the present study provide an important basis
for the use of methanolic extract from G. smeathmannii for the
treatment of infections associated to the microorganisms used in
this study. The crude extract as well as the isolated compounds
found active in this study could be useful for the development of
new antimicrobial drugs. However, further pharmacological and
toxicity studies currently going on in our laboratory will be
necessary to confirm these hypotheses.
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